The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Employment - Kite/Gilead
Stock and Other Ownership Interests - Bristol-Myers Squibb; Gilead Sciences; Seagen
 
Employment - Kite/Gilead
Stock and Other Ownership Interests - Gilead Sciences
 
Honoraria - Kite/Gilead
Consulting or Advisory Role - Amgen; Atara Biotherapeutics; Celgene; Kite/Gilead
Tumor microenvironment associated with increased pretreatment density of activated PD-1+ LAG-3+/− TIM-3− CD8+ T cells facilitates clinical response to axicabtagene ciloleucel (axi-cel) in patients (pts) with large B-cell lymphoma.
 
Jerome Galon
Stock and Other Ownership Interests - HalioDx
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; Bristol-Myers Squibb; Catalym; Gilead Sciences; Gilead Sciences; GlaxoSmithKline; Northwest Biotherapeutics; Roche; Sanofi
Research Funding - AstraZeneca; ImageIQ; IO Biotech; Janssen; MedImmune; Perkin Elmer
Patents, Royalties, Other Intellectual Property - Patent holder: INSERM
 
Nathalie Scholler
No Relationships to Disclose
 
Regis Perbost
Employment - HalioDx
 
Sarah Turcan
Employment - HalioDx
Leadership - HalioDx
Stock and Other Ownership Interests - HalioDx
Travel, Accommodations, Expenses - HalioDx
 
Corinne Danan
Stock and Other Ownership Interests - HalioDx
 
Frederick Lundry Locke
Stock and Other Ownership Interests - Cellular Biomedicine Group
Consulting or Advisory Role - Alimera Sciences; Calibr; Celgene; Cellular Biomedicine Group; EcoR1 Capital; GammaDelta Therapeutics; Gerson Lehrman Group; Novartis; WUGEN, Inc.
Research Funding - Kite, a Gilead company (Inst)
Patents, Royalties, Other Intellectual Property - CAR T Cells with Enhanced Metabolic Fitness. Serial Number: 62/939,727 (Inst); Double Mutant Survivin Vaccine. US010414810B2. (Inst); Evolutionary Dynamics of Non-Hodgkin Lymphoma CAR-T cell therapy. Serial Number: 62/879,534. (Inst); Methods of Enhancing CAR T Cell Therapies. Serial Number: 62/892,292. (Inst)
Travel, Accommodations, Expenses - Kite, a Gilead company
 
Sattva Swarup Neelapu
Honoraria - Aptitude Health; Bio Ascend; Medscape; MJH Life Sciences
Consulting or Advisory Role - Alimera Sciences; Celgene; Cell Medica; Gilead Sciences; Incyte; Kite, a Gilead company; Legend Biotech; Merck Sharp & Dohme; Novartis; Pfizer; Precision Biosciences; Unum Therapeutics
Research Funding - Acerta Pharma; Alimera Sciences; Bristol-Myers Squibb; Cellectis; Gilead Sciences; Karus Therapeutics; Kite, a Gilead company; Merck Sharp & Dohme; poseida therapeutics; Precision Biosciences; Unum Therapeutics
Patents, Royalties, Other Intellectual Property - Patents related to cellular therapy
Travel, Accommodations, Expenses - Alimera Sciences; Celgene; Chugai Pharma; Kite/Gilead; Legend Biotech; Medscape; Merck; Novartis; Pfizer; Precision Biosciences; Unum Therapeutics
 
David Bernard Miklos
Consulting or Advisory Role - Adaptive Biotechnologies; Alimera Sciences; Janssen; Juno/Celgene; Kite, a Gilead company; Miltenyi Biotec; Novartis; Pharmacyclics; Precision Biosciences
Research Funding - Adaptive Biotechnologies; Alimera Sciences; Kite, a Gilead company; Novartis; Novartis; Pharmacyclics; Precision Biosciences; Roche/Genentech
Patents, Royalties, Other Intellectual Property - Patent held with Pharmacyclics supporting Ibrutinib for cGVHD (no royalty claim)
Travel, Accommodations, Expenses - Adaptive Biotechnologies; Juno Therapeutics; Kite, a Gilead company; Miltenyi Biotec; Novartis; Pharmacyclics/Janssen
 
Caron A. Jacobson
Honoraria - Celgene; Humanigen; Kite/Gilead; Nkarta; Novartis; Pfizer; Precision Biosciences
Consulting or Advisory Role - Celgene; Humanigen; Kite/Gilead; Nkarta; Novartis; Pfizer; Precision Biosciences
Speakers' Bureau - Axis Pharma; Clinical Care Options
Research Funding - Pfizer
Travel, Accommodations, Expenses - Celgene; Humanigen; Kite/Gilead; Novartis; Pfizer; Precision Biosciences
 
Lazaros J. Lekakis
Consulting or Advisory Role - Incyte; Janssen; Jazz Pharmaceuticals
 
Yi Lin
Consulting or Advisory Role - Bluebird Bio (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Gamida Cell (Inst); Juno Therapeutics (Inst); Juno Therapeutics (Inst); Kite/Gilead (Inst); Legend Biotech (Inst); Novartis (Inst); Sorrento Therapeutics (Inst); Vineti (Inst)
Research Funding - Bluebird Bio (Inst); Boston Scientific (Inst); Bristol-Myers Squibb (Inst); Janssen Oncology (Inst); Janssen Oncology (Inst); Kite/Gilead (Inst); Merck (Inst); Takeda (Inst)
 
Armin Ghobadi
No Relationships to Disclose
 
Justin Chou
Employment - Kite/Gilead
Stock and Other Ownership Interests - Five Prime Therapeutics; Gilead Sciences
Patents, Royalties, Other Intellectual Property - Five Prime Therapeutics
Travel, Accommodations, Expenses - Kite/Gilead
 
Zixing Wang
Employment - Kite, a Gilead company
 
Allen Xue
Employment - Kite/Gilead
Stock and Other Ownership Interests - Gilead Sciences
 
John M. Rossi
No Relationships to Disclose
 
Adrian Bot
Employment - Gilead Sciences; Kite/Gilead
Stock and Other Ownership Interests - Gilead Sciences
Consulting or Advisory Role - Gilead Sciences
Travel, Accommodations, Expenses - Gilead Sciences